Ultrasound for Assessment of Intra-Abdominal Blood Loss After Gynecological Surgery

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexFemale
Age18-70
SponsorHoly Family Hospital, Nazareth, Israel

About this trial

This is a prospective cohort study designed to assess intra-abdominal blood volume and hemodynamic status by measuring the diameter of the inferior vena cava (IVC) using 3D and Doppler ultrasound within 24 hours after gynecological surgery. The study will examine the association between these ultrasound findings and postoperative outcomes, including hemoglobin drop, need for blood transfusion, pain, infection, and length of hospitalization. Approximately 250 women undergoing laparotomy, laparoscopy, or vaginal surgery at Holy Family Hospital will be enrolled. The study also aimed to define postoperative normograms for fluid volume and IVC parameters and to evaluate whether ultrasound-guided decision-making could improve postoperative care and reduce unnecessary interventions.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Women aged 18 years and older

Undergoing gynecological surgery including laparotomy, laparoscopy, and vaginal pelvic surgery

Able to provide informed consent

Disqualifiers

Undergoing minor procedures (e.g., dilation and curettage, hysteroscopy, or cervical conization)

Known preoperative coagulation disorders

Postoperative admission to the intensive care unit (ICU)

Clinical indication requiring ultrasound as part of standard postoperative care

Trial population

Women aged 18 years and older undergoing gynecological surgery (open, laparoscopic, or vaginal) at Holy Family Hospital in Nazareth, Israel.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Ultrasound

    Diagnostic test

    Transabdominal and transvaginal imaging will be performed to eligible women following gynecological surgery within 24 - 48 hours.

Treatment groups

250 Participants
are divided into 1 treatment group
Group A: Study group1 intervention

Trial outcomes

Primary outcomes

1

Incidence of intra-abdominal free fluid

Detection of any intra-abdominal or pelvic free fluid via ultrasound examination within 24 - 48 hours after gynecological surgery.

Time frame
Within 24-48 hours after surgery

Secondary outcomes

1

Volume of intra-abdominal fluid

Measured in mL using 3D ultrasound

Time frame
Within 24-48 hours after surgery
2

Presence and size of pelvic hematoma

Using ultrasound to identify hematomas and measure their volume

Time frame
Within 24-48 hours after surgery
3

Inferior vena cava (IVC) diameter and collapsibility index

Using ultrasound Doppler to measure Inferior vena cava (IVC) diameter and collapsibility index

Time frame
Within 24-48 hours after surgery
4

Hemoglobin drop

Delta hemoglobin level before surgery and at 48-72 hours postoperatively.

Time frame
Within 24-48 hours after surgery

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.